ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1225

Nailfold Video Capillaroscopy and Its Association with Autoantibodies and Rheumatic Diseases in Pediatric Patients

Yazmin Espinosa1, Sara Concha1, Clara Schulze1 and Antonia Valenzuela2, 1Pontificia Universidad Católica de Chile, Santiago de Chile, Chile, 2Pontificia Universidad Católica de Chile, Santiago, Chile

Meeting: ACR Convergence 2023

Keywords: Autoantibody(ies), Pediatric rheumatology, Raynaud's, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Nailfold video capillaroscopy (NVC) is useful in diagnosing secondary Raynaud’s phenomenon (RP) and predicting systemic sclerosis (SSc) and other CTD in adults. Recent studies indicate its potential application in children with positive antinuclear autoantibodies (ANA), irrespective of the presence of RP. We aimed to evaluate microvascular abnormalities in children using NVC in a cohort of pediatric Chilean patients.

Methods: This cross-sectional study included children between 5 to 18 years with diagnosis of CTD, RP and/or positive ANA. Using a 200 magnification DinoLite microscope, NVC findings were according to the standardized international consensus definitions from the EULAR Study Group on Microcirculation in Rheumatic Diseases into normal, non-specific and SSc patterns. ANA were detected through routine clinical care by indirect immunofluorescence techniques on HEp-2 substrate and/or immunoblotting ANA Profile 23 Ag. Extractable nuclear antibodies (ENA) were detected by Enzyme-Linked Immunosorbent Assay.

Results: 28 children were consecutively included. Median age was 12 years (interquartile range (ICR) 8-14), and 79% were female (n=22). 57% of the patients had CTD/RP (n=16) and 43% (n=12) had a positive ANA without features of CTD/RP. Non-specific abnormalities were the most frequent pattern (n=25, 89%). The SSc pattern was found in 2 patients, and 1 patient had a normal NVC pattern. The patient with normal pattern was a healthy child without CTD and with high titers of DFS70 antibody on ANA immunoblotting. The 2 patients with SScPattern had a clinical diagnosis of MCTD with RP and high titers of RNP/Sm antibody, and exhibit an active SSc pattern on NVC. Patients with positive ANA without CTD/RP had a median of 6.5 capillaries/mm (ICR 6-7) and a median apical diameter of 21,5 μm (ICR 17-24) . Most of them had a non-specific NVC pattern (n=11, 92%), and dilated capillaries were present in 50% (n=6), without microhemorrhages or giant capillaries. Patients with CTD/RP had a median apical diameter of 22.5 μm (ICR 17.5-24). Most of them had dilated capillaries (75%, n=12), and 88% (n=14) had a non-specific pattern. Patients with a positive ANA without CTD/RP had significantly lower median apical diameters than those with CTD/RP (p=0.0091). In univariate analysis, CTD/RP (p=0.0091), and the presence of RP (p=0.0048) were associated with higher median apical diameters. High titers of RNP/Sm antibodies on ENA panel (p=0.0376), positive Sm (p=0.0376), and positive La autoantibodies (p=0.0376) were associated with higher apical diameters. In the ENA panel, high titles of RNP/Sm (p=0.0211), positive Sm (p=0.0211) and positive La (p=0.0211) were associated with fewer capillaries.

Conclusion: This study adds further knowledge of NVC technique and methodology in children and adolescents. Our results highlight the potential utility of regular use of NVC in pediatric patients with positive ANA, RP and CTD.

Supporting image 2


Disclosures: Y. Espinosa: None; S. Concha: None; C. Schulze: None; A. Valenzuela: None.

To cite this abstract in AMA style:

Espinosa Y, Concha S, Schulze C, Valenzuela A. Nailfold Video Capillaroscopy and Its Association with Autoantibodies and Rheumatic Diseases in Pediatric Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/nailfold-video-capillaroscopy-and-its-association-with-autoantibodies-and-rheumatic-diseases-in-pediatric-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nailfold-video-capillaroscopy-and-its-association-with-autoantibodies-and-rheumatic-diseases-in-pediatric-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology